17

Feb

2023

09:33

GMT

Webinar

The Changing Face of Lipid Management in the UK: An Educational Programme for UK-based Healthcare Professionals

Average (ratings)
No ratings
Your rating

Overview

Beta-blockers are routinely prescribed often as first-line therapy for various cardiovascular diseases such as coronary heart disease and heart failure. Much of their prescribing relates to the benefits of the newer generation of beta-blockers and greater cardio-selectivity. One of the challenges all clinicians face is to manage the choice of numerous beta-blockers and in particular translating the evidence base to real-world practice.

This webinar will provide an overview of the evidence of beta-blockers, and present some key differences between the agents. The webinar will also discuss, through the use of cases, the management of patients who are often excluded from clinical trials, in particular the elderly.

This live webinar is EBAC accredited. 1 CME credit will be granted upon confirmation of successful attendance.

This is an independent activity run by the International Society of Cardiovascular Pharmacotherapy (ISCP) and co-produced in collaboration with Radcliffe Cardiology.

Faculty:


Satinder K Sandhu

Satinder K Sandhu


Gaku Nakazawa

Gaku Nakazawa


Martí Puigfel

Martí Puigfel

Agenda

Faculty Biographies

Gaku Nakazawa

View full profile

Satinder K Sandhu

View full profile

Martí Puigfel

View full profile